<http://schema.org/potentialAction>
_:b1
<http://www.genengnews.com/Login.aspx?ReturnURL=%2Fgen-news-highlights%2Fphase-iii-study-shows-exelixis-cabozantinib-nearly-triples-pfs-in-metastatic-medullary-thyroid-%2F81246851%2F>